Coral Laboratories Limited (CORALAB.BO)
INR 747.6
(-3.64%)
INR 747.6
(-3.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 836.6 Million | 778.93 Million | 732.22 Million | 952.05 Million | 682.5 Million | 882.98 Million |
| Cost of Revenue | 504.21 Million | 492.62 Million | 426.44 Million | 537.36 Million | 429.69 Million | 533.24 Million |
| Gross Profit | 332.39 Million | 286.31 Million | 305.77 Million | 414.69 Million | 252.81 Million | 349.73 Million |
| Operating Expenses | 189.75 Million | 270 Million | 243.54 Million | 276.02 Million | 218.64 Million | 244.44 Million |
| Selling, General and Administrative Expenses | 189.75 Million | 31.06 Million | 46.95 Million | 82.64 Million | 24.85 Million | 32.82 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 18.72 Million | 16.81 Million | 17.24 Million | 24.56 Million | 24.99 Million |
| Cost and Expenses | 693.97 Million | 762.62 Million | 669.99 Million | 813.38 Million | 648.33 Million | 777.69 Million |
| Operating Income | 142.63 Million | 18.59 Million | 65.05 Million | 144.12 Million | 41.33 Million | 106.28 Million |
| Interest Expense | 2000.00 | 3.38 Million | 1.41 Million | 425 Thousand | 581 Thousand | 230 Thousand |
| Income Tax Expense | 49.42 Million | 17.8 Million | 28.1 Million | 40.57 Million | 19.86 Million | 52.89 Million |
| Earnings before Tax | 207.31 Million | 82.26 Million | 118.55 Million | 176.12 Million | 91.17 Million | 155.06 Million |
| Net Income | 157.89 Million | 64.45 Million | 90.45 Million | 135.54 Million | 71.3 Million | 102.16 Million |
| Earnings Per Share Basic | 44.19 | 18.04 | 25.32 | 37.94 | 19.96 | 28.60 |
| Earnings Per Share Diluted | 44.19 | 18.04 | 25.32 | 37.94 | 19.96 | 28.60 |
| Weighted Average Shares Outstanding | 3.57 Million | 3.57 Million | 3.57 Million | 3.57 Million | 3.57 Million | 3.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.57 Million | 3.57 Million | 3.57 Million | 3.57 Million | 3.57 Million | 3.57 Million |
| Gross Margin | 0.40 | 0.37 | 0.42 | 0.44 | 0.37 | 0.40 |
| EBIT Margin | 0.27 | 0.14 | 0.18 | 0.21 | 0.16 | 0.20 |
| Profit Margin | 0.19 | 0.08 | 0.12 | 0.14 | 0.10 | 0.12 |
| EBITDA | 227.07 Million | 107.44 Million | 139.87 Million | 198.56 Million | 112.93 Million | 175.76 Million |
| Earnings Before Tax Margin | 0.17 | 0.02 | 0.09 | 0.15 | 0.06 | 0.12 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 316.55 Million | 288.86 Million | 836.6 Million | 180.78 Million | 231.48 Million | 135.47 Million |
| Cost of Revenue | 175.16 Million | 161.97 Million | 504.21 Million | 114.55 Million | 102.5 Million | 66.58 Million |
| Gross Profit | 141.39 Million | 126.88 Million | 332.39 Million | 66.22 Million | 128.98 Million | 68.88 Million |
| Operating Expenses | 38.97 Million | 69.44 Million | 189.75 Million | 50.13 Million | 71.83 Million | 56.92 Million |
| Selling, General and Administrative Expenses | 38.97 Million | 69.44 Million | - | 50.13 Million | 41.07 Million | 29.1 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 15.61 Million | 20.92 Million | 66.32 Million | 14.39 Million | 18.09 Million | 12.91 Million |
| Cost and Expenses | 214.14 Million | 231.42 Million | 693.97 Million | 164.68 Million | 174.34 Million | 123.51 Million |
| Operating Income | 102.41 Million | 57.43 Million | 142.63 Million | 16.09 Million | 57.14 Million | 11.95 Million |
| Interest Expense | 284 Thousand | 2000.00 | 2000.00 | - | - | - |
| Income Tax Expense | 29.7 Million | 19.58 Million | 49.43 Million | 8.19 Million | 15.2 Million | 6.45 Million |
| Earnings before Tax | 117.74 Million | 77.44 Million | 207.31 Million | 29.76 Million | 75.23 Million | 24.86 Million |
| Net Income | 88.04 Million | 57.87 Million | 157.89 Million | 21.56 Million | 60.03 Million | 18.41 Million |
| Earnings Per Share Basic | 24.64 | 16.20 | - | 6.04 | 16.81 | 5.16 |
| Earnings Per Share Diluted | 24.64 | 16.20 | - | 6.04 | 16.81 | 5.16 |
| Weighted Average Shares Outstanding | 3.57 Million | 3.57 Million | 3.57 Million | 3.57 Million | 3.57 Million | 3.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.57 Million | 3.57 Million | 3.57 Million | 3.57 Million | 3.57 Million | 3.57 Million |
| Gross Margin | 0.45 | 0.44 | 0.40 | 0.37 | 0.56 | 0.51 |
| EBIT Margin | 0.34 | 0.22 | - | 0.12 | 0.34 | 0.22 |
| Profit Margin | 0.28 | 0.20 | 0.19 | 0.12 | 0.26 | 0.14 |
| EBITDA | 107.35 Million | 62.46 Million | - | 21 Million | 79.6 Million | 30.31 Million |
| Earnings Before Tax Margin | 0.32 | 0.20 | 0.17 | 0.09 | 0.25 | 0.09 |
PENINLAND
300805
RNDOF
MEDICO
MDRNSTL
GALXBRG